Federated Hermes, Inc. Aytu Biopharma, Inc Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.15 - $4.0 $185 - $4,952	-1,238 Reduced 21.39%	4,551 $0
Q3 2022 Nov 14, 2022	SELL	$0.19 - $3.8 $175 - $3,503	-922 Reduced 13.74%	5,789 $1,000
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.08 $495 - $1,164	1,078 Added 19.14%	6,711 $5,000
Q1 2022 May 13, 2022	BUY	$1.08 - $1.55 $2,621 - $3,761	2,427 Added 75.7%	5,633 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $2.95 $3,431 - $7,498	2,542 Added 382.83%	3,206 $4,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $5.12 $1,845 - $3,399	664 New	664 $2,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.